Many patients diagnosed with dry eye are actually experiencing ocular pain that may stem from the ocular surface, the nerves, ...

Innovation in therapeutics has a lot on the horizon, he said, but all of those drugs and innovations can only be delivered by ...

At AAO 2026, Michael T. Yen, MD, explained how at-home subcutaneous elegrobart could ease treatment burden in thyroid eye ...

Koreishi, MD, explains why inflammation control and planning are key to cataract surgery for patients with uveitis.

The US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to ...

Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months.

Keith Warren, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...

In addition to the results, Roche also announced that the US Food and Drug Administration (FDA) has accepted the company’s ...

Liza M. Cohen, MD, explains when to use CT vs MRI in thyroid eye disease and why to review images yourself.

Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...

EURETINA President Nicole Eter, MD, picks the sessions busy clinicians should follow at the 26th EURETINA Congress in Vienna, from durability data to AI. She also explains why early referral is still ...

David F. Chang, MD, explained how offering complementary refractive IOLs reduces patient anxiety and indecision.